TN2015000280A1 - Topical Ophthalmological Pharmaceutical Composition containing Regorafenib - Google Patents

Topical Ophthalmological Pharmaceutical Composition containing Regorafenib

Info

Publication number
TN2015000280A1
TN2015000280A1 TNP2015000280A TN2015000280A TN2015000280A1 TN 2015000280 A1 TN2015000280 A1 TN 2015000280A1 TN P2015000280 A TNP2015000280 A TN P2015000280A TN 2015000280 A TN2015000280 A TN 2015000280A TN 2015000280 A1 TN2015000280 A1 TN 2015000280A1
Authority
TN
Tunisia
Prior art keywords
pharmaceutical composition
composition containing
ophthalmological pharmaceutical
topical ophthalmological
containing regorafenib
Prior art date
Application number
TNP2015000280A
Other languages
English (en)
Inventor
Michael Böttger
Julia Freundlieb
Claudia Hirth-Dietrich
Jürgen Klar
Uwe Muenster
Andreas Ohm
Annett Richter
Bernd Riedl
Degenfeld Georges Von
Joerg Keldenich
Petra Heinrich-Keldenich
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of TN2015000280A1 publication Critical patent/TN2015000280A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
TNP2015000280A 2012-12-21 2015-06-18 Topical Ophthalmological Pharmaceutical Composition containing Regorafenib TN2015000280A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12198892 2012-12-21
PCT/US2013/077358 WO2014100797A1 (fr) 2012-12-21 2013-12-21 Composition pharmaceutique ophtalmologique topique contenant régorafénib

Publications (1)

Publication Number Publication Date
TN2015000280A1 true TN2015000280A1 (en) 2016-10-03

Family

ID=47458742

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2015000280A TN2015000280A1 (en) 2012-12-21 2015-06-18 Topical Ophthalmological Pharmaceutical Composition containing Regorafenib

Country Status (27)

Country Link
US (2) US20140179745A1 (fr)
EP (1) EP2934481A1 (fr)
JP (1) JP2016507505A (fr)
KR (1) KR20150100670A (fr)
CN (1) CN104955443A (fr)
AP (1) AP2015008493A0 (fr)
AR (1) AR094104A1 (fr)
AU (1) AU2013364004A1 (fr)
BR (1) BR112015014078A2 (fr)
CA (1) CA2895804A1 (fr)
CL (1) CL2015001701A1 (fr)
CR (1) CR20150327A (fr)
CU (1) CU20150063A7 (fr)
DO (1) DOP2015000155A (fr)
EA (1) EA201500669A1 (fr)
EC (1) ECSP15026386A (fr)
IL (1) IL238791A0 (fr)
MA (1) MA38215A1 (fr)
MX (1) MX2015007488A (fr)
PE (1) PE20151784A1 (fr)
PH (1) PH12015501407A1 (fr)
SG (1) SG11201503838WA (fr)
TN (1) TN2015000280A1 (fr)
TW (1) TW201431568A (fr)
UY (1) UY35183A (fr)
WO (1) WO2014100797A1 (fr)
ZA (1) ZA201505196B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3458031A4 (fr) * 2016-05-16 2020-01-22 Delivra Inc. Formulations transdermiques pour l'administration de célécoxib et leur utilisation dans le traitement de maladies et de pathologies sensibles au celcoxib
CN112834485B (zh) * 2021-02-07 2022-03-29 西南交通大学 激光诱导击穿光谱元素定量分析的一种非定标方法
KR102413226B1 (ko) 2021-08-26 2022-06-23 충북대학교 산학협력단 레고라페닙을 유효성분으로 포함하는 항노화 조성물
KR20230166353A (ko) 2022-05-30 2023-12-07 (주) 레비레스코 감태 추출물, 귤피 추출물, 및 녹차 추출물을 유효성분으로 포함하는 자외선에 대한 세포 보호용 또는 mmp-1 발현 억제용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ580384A (en) * 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
PL1885336T3 (pl) 2005-05-10 2009-08-31 Alcon Inc Kompozycja w postaci zawiesiny zawierająca substancję aktywną, poloksamerowy lub meroksapolowy surfaktant i glikol oraz zastosowanie kompozycji do wytwarzania leku do leczenia chorób oczu
EP1893216A4 (fr) 2005-06-08 2012-08-08 Targegen Inc Methodes et preparations pour le traitement de troubles oculaires
US20080293691A1 (en) 2005-11-29 2008-11-27 Smithkline Beecham Corporation Treatment Method
EP1962828A1 (fr) * 2005-12-15 2008-09-03 Bayer HealthCare AG Diaryle-uree pour le traitement de maladies inflammatoires de la peau, l'oeil et/ou l'oreille
WO2007076358A1 (fr) 2005-12-23 2007-07-05 Alcon, Inc. Preparation pharmaceutique pour l'administration, dans l'oeil, de composes inhibiteurs des récepteurs tyrosine kinases (rtki)
WO2008027341A2 (fr) 2006-08-30 2008-03-06 Merck & Co., Inc. Formulations ophtalmiques locales
AR062927A1 (es) 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
EP3165606A1 (fr) 2009-05-01 2017-05-10 Ophthotech Corporation Procédés de traitement ou de prévention de maladies ophtalmologiques
CN102573477A (zh) 2009-07-16 2012-07-11 葛兰素惠尔康制造业私人有限公司 治疗方法
JP5998213B2 (ja) * 2011-06-28 2016-09-28 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ レゴラフェニブを含有する眼科用局所医薬組成物

Also Published As

Publication number Publication date
JP2016507505A (ja) 2016-03-10
US20150328145A1 (en) 2015-11-19
DOP2015000155A (es) 2015-08-31
EA201500669A1 (ru) 2015-12-30
CL2015001701A1 (es) 2015-10-16
MX2015007488A (es) 2015-09-04
AP2015008493A0 (en) 2015-05-31
IL238791A0 (en) 2015-06-30
AU2013364004A1 (en) 2015-06-04
AR094104A1 (es) 2015-07-08
WO2014100797A1 (fr) 2014-06-26
MA38215A1 (fr) 2017-01-31
CR20150327A (es) 2015-09-14
TW201431568A (zh) 2014-08-16
PH12015501407A1 (en) 2015-09-07
ZA201505196B (en) 2017-11-29
CA2895804A1 (fr) 2014-06-26
UY35183A (es) 2014-07-31
SG11201503838WA (en) 2015-07-30
ECSP15026386A (es) 2016-01-29
BR112015014078A2 (pt) 2018-05-15
CU20150063A7 (es) 2015-11-27
KR20150100670A (ko) 2015-09-02
PE20151784A1 (es) 2015-11-25
EP2934481A1 (fr) 2015-10-28
CN104955443A (zh) 2015-09-30
US20140179745A1 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
PH12015500460B1 (en) Coated pharmaceutical composition containing regorafenib
WO2013188273A8 (fr) Composition pharmaceutique ophtalmique topique contenant de l'axitinib
TN2013000533A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
PH12015500587A1 (en) Combination of regorafenib and acetylsalicylic acid for treating cancer
WO2013188268A8 (fr) Composition pharmaceutique ophtalmique topique contenant du pazopanib
MX2015017861A (es) Derivados de benzotiofeno como inhibidores del receptor de estrogeno.
WO2013188283A8 (fr) Composition pharmaceutique ophtalmique topique contenant du sunitinib
MX2014000779A (es) Derivados de carboxamida y urea que contienen pirazol heteroaromatico sustituido como ligandos del receptor de vanilloide.
NZ711424A (en) Pyridine derivatives as soft rock inhibitors
WO2013147649A3 (fr) Inhibiteurs de la voie de signalisation pi3k/akt/ikk/nf-kb, leurs sels pharmaceutiquement acceptables et compositions les comprenant pour la prévention et le traitement de maladies virales
MX2014000964A (es) Derivados aza heterociclicos sustituidos.
TN2015000280A1 (en) Topical Ophthalmological Pharmaceutical Composition containing Regorafenib
WO2013188279A8 (fr) Composition pharmaceutique ophtalmique topique contenant du cediranib
MX2014000963A (es) Derivados de carboxamida y urea aromaticos biciclicos sustituidos como ligandos del receptor de vanilloide.
MX2014003584A (es) Derivados de metanosulfonamida sustituidos como ligandos de receptores vaniloides.
WO2012072791A3 (fr) Dérivés de 2-(1-phényl-4,5,6,7-tétrahydro-1h-indazol-4-yl)éthylamine utiles en tant qu'inhibiteurs des récepteurs sigma
DOP2015000049A (es) Composición farmacéutica recubierta que contiene regorafenib
IN2013MU03838A (fr)